Yiling Pharmaceutical's controlling shareholder extends share pledge for financing

Shijiazhuang Yiling Pharmaceutical (SZSE:002603) has announced that its actual controlling person, Mr. Wu Xiangjun, has extended the pledge on a portion of his shares. On October 17, 2025, the company was notified that 15,000,000 shares, representing 4.31% of Mr. Wu's total holdings and 0.90% of the company's total share capital, were re-pledged. The original pledge, which began on September 18, 2024, has now been extended until September 18, 2026. This transaction was facilitated by CITIC Securities Co., Ltd. for financing purposes.

Mr. Wu Xiangjun’s current total holdings amount to 347,728,119 shares, with 15,000,000 shares (4.31% of his holdings) now subject to this extended pledge. He also maintains unpledged shares amounting to 260,796,089.

The company stated that Mr. Wu Xiangjun possesses good credit and repayment capacity, indicating controllable pledge risks. This extension is not expected to alter the company’s actual control, nor impact its operations or corporate governance. Should any liquidation risk arise, Mr. Wu has committed to taking measures such as supplementary pledges or early repurchases to mitigate the risk.